NASDAQ:IOVA

Iovance Biotherapeutics Stock Predictions

etoro logo Buy IOVA
*Your capital is at risk
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

IOVA Prediction Chart

IOVA Predictions History

Latest community submissions for IOVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 1, 2026 $3.65 +9.94% $3.45 V 94.20% 0
Mar 31, 2026 $3.45 +4.01% $3.51 V 98.38% 1
Mar 31, 2026 $3.40 +2.51% $3.51 V 96.96% 1
Mar 31, 2026 $3.51 +0.00% $3.51 X 100.00% 9
Mar 25, 2026 $3.76 +3.92% $3.75 V 99.68% 5
Mar 25, 2026 $3.71 +2.45% $3.75 V 98.90% 2
Mar 25, 2026 $3.66 +1.10% $3.75 V 97.60% 1
Mar 24, 2026 $3.71 +2.20% $3.62 X 97.51% 0
Mar 13, 2026 $4.24 +4.10% $3.96 X 93.00% 0
Mar 13, 2026 $4.17 +2.56% $3.96 X 94.59% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IOVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IOVANCE BIOTHERAPEUTICS, INC.
Iovance Biotherapeutics
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or pers...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE